Assured Guaranty Ltd. (AGO), Tripadvisor Inc (TRIP): Do You Own This $2 Billion Hedge Fund’s Best Stock Picks?

Smaller cap stocks don’t get as much attention from bankers, analysts, and most other investors. Generally speaking, this leaves them less-efficiently priced than their larger peers. Hedge funds take advantage of this by dedicating their research teams to work on the little guys, and consequently, they produce a significant amount of their alpha from the small-caps. According to our analysis, investing in the smart money’s top small-cap picks has generated an annual alpha of more than 15 percentage points per month between 1999 and 2009 (learn more about this phenomenon here).

BRIDGER MANAGEMENTLet’s take a look at the top small-cap stock picks of one hedge fund in particular: Roberto Mignone’s Bridger Management. The stocks listed here had market capitalizations between $1 billion and $5 billion at the end of the third quarter, which is consistent with the criterion used in our strategy (see all of Roberto Mignone’s stock picks).

Assured Guaranty Ltd. (NYSE:AGO) is Mignone’s top small-cap holding, sitting at the No. 5 spot in his latest 13F filing with the SEC. Assured Guaranty’s subsidiaries offer a range of credit-related services to infrastructure projects, state governments and utility districts. Shares of the insurer are up more than 25% on the year, and it will report its fourth quarter earnings in close to a month. Assured Guaranty is coming off of two consecutive EPS beats by an average margin of 12.2%. A PEG ratio near 0.5 and a forward earnings valuation under 7x indicates that investors could see more upside if the company can impress with Q4 results. It’s tough to argue with Mignone here.

The fund manager’s second largest small-cap investment is Tripadvisor Inc (NASDAQ:TRIP). Shares of the online travel site have been a great investment over the past 12 months, returning a little over 45% in value. While Tripadvisor looks a little overvalued at the moment, the sell-side is expecting bottom line growth in excess of 20% annually over the next two years, so there are reasons for momentum-seeking investors to remain bullish. Over the long, long run, Tripadvisor has Google problems, as the tech giant’s acquisition of ITA Software gives it a greater foothold in this space. Still, for those focused on the shorter term, Tripadvisor offers solid growth.

Who’s the best of the rest?

Avis Budget Group (NASDAQ:CAR) is Mignone’s third largest small-cap holding, sitting at the No. 15 spot in his entire portfolio. Avis has been a booming investment over the past 3-month (32.7%), 6-month (47.0%) and 12-month (48.7%) periods, indicating that investors are using the stock to buy in on the bullish car rental marketplace. Avis announced it would acquire car-sharing service Zipcar earlier in January, and assuming that anti-trust regulators don’t put a stop to the deal, it should be completed by this spring.

Avis’ earnings currently trade at a 13% discount to the rental industry’s average, and Wall Street expects accelerating EPS growth over the next half-decade. Analysts predict 29.7% annual growth compared to Avis’ 13.9% average over the past five years.

Charles River Laboratories (NYSE:CRL), meanwhile, is Mignone’s fourth favorite small-cap stock, and is already up more than 10% year-to-date. The biotech company wasupgraded to overperform by JPMorgan and Wells Fargo at the end of last year, and it recently completed its acquisition of majority ownership of Vital River, a Chinese research model servicer. Charles River has beaten the Street’s earnings forecasts in four consecutive quarters, and reports its fiscal Q4 results about two weeks from now. If the company can meet or beat the sell-side’s 60-cent EPS and $281 million revenue estimates, shares could appreciate further. Charles River currently trades at a modest 14.5 times forward EPS, which is below peers Life Technologies and Idexx Labs by an average discount of 31%.

Last but certainly not least, Ironwood Pharmaceuticals (NASDAQ:IRWD) is Roberto Mignone and Bridger Management’s fifth largest small-cap holding, sitting at the No. 23 spot in the fund’s 13F portfolio. Ironwood may be best known for its drug Linzess, which is prescribed to those suffering from chronic constipation and irritable bowel syndrome. Some analysts think Ironwood’s drug can become a billion-dollar-a-year giant (see Will This Drug Be a Cash Cow?), and the company did report a blowout third quarter in its latest earnings.

A couple weeks ago, the stock saw major downgrades from UBS, Zacks and TheStreet, but Mizuho, WallachBeth and Ladenburg Thalmann raised their price targets. Still, at elevated price-to-sales (9.3x) and book (9.7x) multiples, it may be best for investors to find a more attractive entry point into Ironwood.

Disclosure: I have no positions in any of the stocks mentioned above

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

50 Crazy Facts About Japan You Won’t Believe

Top 10 Least Expensive Hybrid Cars to Save the Planet With

The 10 Biggest ‘Gate’ Controversies in History

The 10 States with the Highest Nursing Shortages Leaving Their Hospitals Depleted

The 10 Best Value Investment Blogs that Every Investor Must Read

The 6 Cheapest Boarding Schools in Europe 2015

The 5 Most Expensive Cars To Insure in the World

The 10 Most Common Genetically Modified Foods

10 Self-Made Billionaires Who Came From Nothing

The 10 Most Expensive Cities to Live in North America

The 13 Most Expensive Headphones in the World to Represent

The Top 20 Wealthiest Soccer Teams in 2014

4 BuzzWorthy Cannabis Stocks And Some Smoking Derivative Plays

The 10 Healthiest Fast Food Chains in America to Dine At

The 5 Most Expensive Cat Food Brands You Can Spoil Your Kitty With

The 6 Best eCommerce Platforms for Small Businesses

The 10 Worst Mistakes an Entrepreneur Can Make

The 5 Most OP Characters in League of Legends to Carry Games and Crush Foes With

The 5 Best Foods to Eat Before Running that Will Help You Pound the Pavement

10 Glaring Plot Holes in The Walking Dead that a Zombie-Filled Bus Could Drive Through

The 5 Biggest Celebrity Stoners Who Love Their Reefer

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

How to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!